<DOC>
	<DOC>NCT01800812</DOC>
	<brief_summary>Methods Patients received OM-174 twice weekly for a total of 5, 10 or 15 injections of either 600, 800 or 1000 µg/m². Pharmacokinetic analysis and cytokine dosages were performed. Natural Killer cells activity and toll-like receptors 4 polymorphism analysis were also performed.</brief_summary>
	<brief_title>Effects of OM-174 in Adult Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Patient with a histologically proven solid tumor, refractory to conventional treatment or for which no such treatment existed. At least one month since the last chemotherapy Life expectancy above 3 months Written informed consent Age above 18 Patient's refusal Infection Brain metastasis Autoimmune disease Regular use of steroids Patient included in another protocol Chemotherapy or radiotherapy less than 6 weeks ago Immunotherapy less than 8 weeks ago</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>